AstraZeneca PLC

🏆 Defensive sector dominance – Pure health care exposure shields against broad market volatility, outperforming in recessionary and risk-off regimes.

---

⚠️ Geopolitical and concentration risk – 100% European exposure amplifies policy shocks, currency swings, and regulatory upheavals; no diversification buffers systemic crises.

---

🔍 Structural underweight in growth cycles – Defensive bias stifles upside in high-growth macro regimes; liquidity-driven rebounds rare without earnings expansion tailwinds.

🏆 Defensive sector dominance – Pure health care exposure shields against broad market volatility, outperforming in recessionary and risk-off regimes.

---

⚠️ Geopolitical and concentration risk – 100% European exposure amplifies policy shocks, currency swings, and regulatory upheavals; no diversification buffers systemic crises.

---

🔍 Structural underweight in growth cycles – Defensive bias stifles upside in high-growth macro regimes; liquidity-driven rebounds rare without earnings expansion tailwinds.